ARC in Hemorrhagic Stroke

Completed

Conditions studied: Hemorrhagic Stroke, Augmented Renal Clearance

In brief

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Key facts

Study ID

NCT02386202

Run by

University of North Carolina, Chapel Hill

People needed

80

Starts

2015-01-01

Expected to finish

2015-08-01

Last updated by the study team

2015-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ≥ 18 years
• Patients with hemorrhagic stroke
• Anticipated length of stay in the neuroscience intensive care unit > 48 hours
• Informed consent provided by the patient or by the patient's designated medical proxy

You may not qualify if…

• Pregnancy
• Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
• Patients receiving renal replacement therapy
• Patients with an admission serum creatinine > 1.4 mg/dL
• Patients with non-aneurysmal subarachnoid hemorrhage
• Patients with history of nephrectomy or body mass index < 18 kg/m2

Where it is running

• University of North Carolina Hospitals — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.